Atrial septostomy to prevent pulmonary hypertension crisis in children with ventricular septal defect (VSD) and pulmonary hypertension (PH) underwent cardiac surgery: a case series
Haryo Aribowo(1*), Yoga Arditya(2), Gita Christy Gabriela(3)
(1) Division of Cardiac, Thoracic, and Vascular Surgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing/Dr. Sardjito General Hospital, Yogyakarta 55281, Indonesia.
(2) Division of Cardiac, Thoracic, and Vascular Surgery, Department of Surgery, Faculty of Medicine, Public Health, and Nursing/Dr. Sardjito General Hospital, Yogyakarta 55281, Indonesia.
(3) Department of Surgery, Faculty of Medicine, Public Health, and Nursing/Dr. Sardjito General Hospital, Yogyakarta 55281, Indonesia.
(*) Corresponding Author
Abstract
Severe pulmonary hypertension (PH) was reported in 22.4% of ventricular septal defect (VSD) and it was mainly seen on a large VSD. Atrial septostomy (AS) could improve the hemodynamic condition and long-term survival of PH patients. Here, three VSD and PH cases in children who underwent AS surgery as their early treatment, concomitant with PH-specific pharmacological treatment were reported. Patient’s hemodynamic and general condition improved with no further complications during the follow-up period. Atrial septostomy was usually conducted after all PH-specific pharmacological interventions failed. However, a study found that the survival benefit of AS was significantly increased if it was conducted before PH-specific pharmacotherapies. Most of the patients in this case received immediate hemodynamic and functional improvement. In this case series, it was reported that the AS procedure could lower the pulmonary arterial pressure and be safely conducted without further complications or death >24 hr post-surgery. Considering the clinical benefit, safety procedure, and improved pulmonary arterial pressure, performing AS procedure concomitant with PH-specific pharmacotherapy as an early treatment for PH patients is recommended.
Keywords
Full Text:
PDFReferences
Penny DJ, Vick GW 3rd. Ventricular septal defect. Lancet 2011; 377(9771):1103-12.
https://doi.org/10.1016/S0140-6736(10)61339-6
2.Chaudhry TA, Younas M, Baig A. Ventricular septal defect and associated complications. J Pak Med Assoc 2011; 61(10):1001-4.
3.Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation 1999; 99(9):1197-208.
https://doi.org/10.1161/01.cir.99.9.1197
4.Grady RM. Beyond transplant: roles of atrial septostomy and Potts shunt in pediatric pulmonary hypertension. Pediatr Pulmonol 2021; 56(3):656-60.
https://doi.org/10.1002/ppul.25049
5.Haworth SG, Hislop AA. Treatment and survival in children with pulmonary arterial hypertension: the UK Pulmonary Hypertension Service for Children 2001-2006. Heart 2009; 95(4):312-7.
https://doi.org/10.1136/hrt.2008.150086.
6.Zijlstra WMH, Douwes JM, Rosenzweig EB, Schokker S, Krishnan U, Roofthooft MTR, et al. Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies. J Am Coll Cardiol 2014; 63(20):2159-69.
https://doi.org/10.1016/j.jacc.2014.02.575
7.Sandoval J, Rothman A, Pulido T. Atrial septostomy for pulmonary hypertension. Clin Chest Med 2001; 22(3):547-60.
https://doi.org/10.1016/s0272-5231(05)70291-4
8.Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992; 327(2):76-81.
https://doi.org/10.1056/NEJM199207093270203
9.Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997; 336(2):111-7.
https://doi.org/10.1056/NEJM199701093360207
10.Kurzyna M, Dabrowski M, Bielecki D, Fijalkowska A, Pruszczyk P, Opolski G, et al. Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest 2007; 131(4):977-83.
https://doi.org/10.1378/chest.06-1227
11.Maluli HA, DeStephan CM, Alvarez RJ, Sandoval J. Atrial septostomy: a contemporary review. Clin Cardiol 2015; 38(6):395-400.
https://doi.org/10.1002/clc.22398
12.Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J 1986; 55(5):449-58.
https://doi.org/10.1136/hrt.55.5.449
13.Sandoval J, Gaspar J, Peña H, Santos LE, Cordova J, del Valle K, et al. Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension. Eur Respir J 2011; 38(6):1343-8.
https://doi.org/10.1183/09031936.00072210
14.Reichenberger F, Pepke-Zaba J, McNeil K, Parameshwar J, Shapiro LM. Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax 2003; 58(9):797-800.
https://doi.org/10.1136/thorax.58.9.797
15.Austen WG, Morrow AG, Berry WB. Experimental studies of the surgical treatment of primary pulmonary hypertension. J Thorac Cardiovasc Surg 1964; 48:448-55.
https://doi.org/10.1016/S0022-5223(19)33542-1
16.Glanville AR, Burke CM, Theodore J, Robin ED. Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation. Chest 1987; 91(5):675-81.
https://doi.org/10.1378/chest.91.5.675
17.Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996; 15(1 Pt 1):100-5.
18.Law MA, Grifka RG, Mullins CE, Nihill MR. Atrial septostomy improves in select patients with pulmonary hypertension. Am Heart J 2007; 153(5):779-84.
https://doi.org/10.1016/j.ahj.2007.02.019
DOI: https://doi.org/10.19106/JMedSci005501202303
Article Metrics
Abstract views : 1124 | views : 1427Copyright (c) 2023 Gita Christy Gabriela
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.